NGAL (Neutrophil Gelatinase-Associated Lipocalin) as an early biomarker of nephropathy in patients with type 2 diabetes
MHZ Megallaa, MS Abdel Salam… - Alexandria Journal of …, 2023 - Taylor & Francis
Background and aim Diabetic nephropathy (DN) is a major microvascular diabetic
complication representing the key leading reason for end-stage renal disease (ESRD). The …
complication representing the key leading reason for end-stage renal disease (ESRD). The …
[HTML][HTML] Lipocalin-2 as a biomarker for diabetic nephropathy
PP Kiran Dahiya, R Dhankhar, K Dhankhar… - World Journal of Meta …, 2023 - wjgnet.com
Diabetes is a major global public health issue. The prevalence of type 1 diabetes is
comparatively static, as hereditary and genetic causes are involved, while type 2 diabetes …
comparatively static, as hereditary and genetic causes are involved, while type 2 diabetes …